3Engman M, Granberg S, Williams AR, et al. Mifepris- tone for treatment of uterine leiomyoma, a prospective randomized placebo controlled trial [ J ]. Hum Reprod, 2009 ( 8 ) : 1870 - 1879.
4Ohara N, Morikawa A, Chen W, et al. Comparative effects of SPRM asoprisnil (J867) on proliferation, apop- tosis, and the expression of growth factors in cultured u- terine leiomyoma cells and normal myometrial cells [ J ]. Reprod Sci,2007 ( 8 Suppl ) : 20 - 7.
5Engman M, Granberg S,Williams AR,et al. Mifepristone for treat- ment of uterine leiomyoma, a prospective randomized placebo con- trolled trial [ J ]. Hum Reprod ,2009,24 ( 8 ) : 1870 - 1879.
6Narvekar N,Critchley HO, Cheng L,et al. Mifepristone-induced am- enorrhoea is associated with an increase in microvessel density and glucocorticoid receptor and adecrease in stromal vascular endothelial growth factor[J]. Hum Reprod,2006,21(9):2312-2318.
7Esteve JL-C,AcostaR,Perez Y,et al.Treatment of uter ine myoma with 5 or 10 mg mifepristone daily during 6 months,post-treatment evolution over 12 months:Doub-le-blind randomised clinical trial[J].Euopean Journal of Obstetrics,Gynecology and Reproduc-tive Biology,2012,161(2):202-208.
8Feng C,Meldrum S,Fiscella K.et al.Improved quality of life is partly explained by fewer symptoms after treatment of fibroids with mifepristone.[J].International iournal of gynecology and obstetrics,2010,109(2):121-124.
